This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

Register by April 25 to Save $200

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA
Book Now
Menu
Book

Dr. Kellan Passow, PhD
Scientist II at Aligos Therapeutics
Speaker

Profile

Dr. Passow graduated from the University of Minnesota in 2020, studying topics spanning medicinal chemistry, chemical biology, nucleoside chemistry, and oligonucleotide chemistry. Since joining Aligos Therapeutics, Kellan has been a member of the oligonucleotide chemistry team, specializing in the development and expansion of Aligos’ chemistry platform across a broad range of projects. He enjoys making the most of the outdoors with his friends, whether it’s a national park or visiting a local brewery.

Agenda Sessions

  • Design, Synthesis, and Characterization of Novel 2ʹ-O-Substituted siRNAs for Targeting Hepatitis B Virus

    , 11:45am
    View Session

At this event

Prev
Next
Tao Pei, PhD
Senior Vice President, Chemistry
Arrowhead Pharmaceuticals

See Kellan at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now